ArthroCare (ARTC) Misses Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ARTC Hot Sheet
Price: $10.01 -0.3%
Financial Fact:
Basic (in shares): 31.84M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Basic (in shares): 31.84M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
ArthroCare (NASDAQ: ARTC) reported Q3 EPS of $0.32, $0.05 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $96.1 million versus the consensus estimate of $96 million.
For earnings history and earnings-related data on ArthroCare (ARTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Western Union (WU) Tops Q3 EPS by 8c; offers guidance
- ZoomInfo Technologies Inc. (GTM) Reports In-Line Q3 EPS; Offers Guidance
- e.l.f. Beauty, Inc. (ELF) Tops Q2 EPS by 64c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
